Top five generic medicines supplier globally

Generic medicines are the medicines which are similar is all aspect i.e. strength, dosage form, efficacy, potency, results indication etc to its patent brand.  The global generic drug market is growing as demand for more accessible medication is increasing. The global generic drug market is expected to grow at CAGR of 8.7% from $ 352 billion in 2016 to $ 533 billion to 2021.

Generic medicines are equivalent in all aspects to branded medicines but cost of generic medicines is much lesser than their branded versions. That is making generic medicines more popular.

Here we are providing list of generic drug makers by total revenue. List is as follow:

Teva Pharmaceuticals Industries Limited:

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. Established in Jerusalem in 1901, the company known today as Teva starts out as a small wholesale drug business that distributes imported medications. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients . Teva is the world’s leading generic drug maker having $18.9 billion annual turnover. Teva has approx. 43000 employees worldwide.

Mylan NV:

Mylan N.V. is a global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a “Global Center” in Canonsburg, Pennsylvania, US. Mylan operates in over 165 countries with approximate 35000 employee globally. Mylan having Mylan is founded in 1961 in West Virginia. Mylan has more than 7500 products including prescription generic, branded generic, brand-name and biosimilar drugs, as well as over-the-counter (OTC) remedies. Mylan is second largest generic supplier globally having $ 11.87 billion revenue in 2017.

Sandoz:

Sandoz is a generic pharmaceuticals and bio similar division of the Novartis group. It’s now third largest generic supplier having revenue of $ 9.9 billion worldwide.

In 1996, Ciba-Geigy merged with Sandoz; the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz having headquartered in Munich, Germany.

Sun Pharmaceuticals:

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients has over 40 manufacturing site, over 2,000 marketed products and over 30,000 employees worldwide having revenue of 7.8 billion in 2018. Established in 1983, Sun Pharma sold products across India before expanding internationally in 1996.

Lupin:

Lupin Limited, headquartered in Mumbai, India. Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. 

Lupin was founded in 1968 by Desh Bandu Gupta. In 2003, Lupin Pharmaceuticals Inc, USA is formed for trading, marketing and developmental activities in the US. The drugs produced by Lupin reportedly reach 70 countries with a footprint that covers advanced markets such as USA, Europe, Japan, Australia as well as emerging markets including India, the Philippines and South Africa to name a few.